Chemours
416 hedge funds and large institutions have $3.13B invested in Chemours in 2016 Q4 according to their latest regulatory filings, with 92 funds opening new positions, 99 increasing their positions, 132 reducing their positions, and 47 closing their positions.
96% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 47
83% more call options, than puts
Call options by funds: $56.7M | Put options by funds: $31M
42% more capital invested
Capital invested by funds: $2.19B → $3.13B (+$932M)
10% more funds holding
Funds holding: 377 → 416 (+39)
1.94% more ownership
Funds ownership: 76.1% → 78.04% (+1.9%)
25% less repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 132
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$186M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$124M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$73.9M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$49.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Greenlight Capital
New York
|
-$152M |
| 2 |
SC
Sessa Capital
New York
|
-$99.4M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
-$83.6M |
| 4 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$48.8M |
| 5 |
FCP
Fine Capital Partners
New York
|
-$32.3M |
CC Hedge Fund Activity: Q4 2016 in Review
416 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q4 2016, worth a combined $3.13B — up 42% from $2.19B a quarter earlier.
Buyers outnumbered sellers: 92 funds opened new CC positions and 47 closed out — a net gain of 45 holders — while 99 added to existing stakes and 132 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $186M. The largest seller was Greenlight Capital, cutting an estimated $152M.
- 416 institutional investors held Chemours (CC) as of Q4 2016, up from 377 in Q3 2016.
- Funds reported $3.13B of Chemours stock for Q4 2016, up 42% quarter-over-quarter.
- 92 funds opened new Chemours positions in Q4 2016 and 47 closed out, a net change of +45 holders.
- The largest Chemours buyer in Q4 2016 was Fidelity Investments, an estimated $186M added.
- The largest Chemours seller in Q4 2016 was Greenlight Capital, an estimated $152M sold.
Based on aggregated 13F filings for Q4 2016.